Richard Peters
2018 - Merrimack Pharmaceuticals
In 2018, Richard Peters earned a total compensation of $3.3M as Former President and Chief Executive Officer at Merrimack Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $610,161 |
|---|---|
| Option Awards | $1,954,148 |
| Salary | $722,084 |
| Other | $10,042 |
| Total | $3,296,435 |
Peters received $2M in option awards, accounting for 59% of the total pay in 2018.
Peters also received $610.2K in non-equity incentive plan, $722.1K in salary and $10K in other compensation.
Rankings
In 2018, Richard Peters' compensation ranked 3,486th out of 14,244 executives tracked by ExecPay. In other words, Peters earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,486 out of 14,244 | 76th |
Division Manufacturing | 1,286 out of 5,765 | 78th |
Major group Chemicals And Allied Products | 450 out of 2,128 | 79th |
Industry group Drugs | 371 out of 1,817 | 80th |
Industry Pharmaceutical Preparations | 284 out of 1,391 | 80th |
Source: SEC filing on September 26, 2019.
Peters' colleagues
We found two more compensation records of executives who worked with Richard Peters at Merrimack Pharmaceuticals in 2018.
News
KINETA CEO Richard MDPhD receives $4.5M in 2021
April 25, 2022
KINETA CEO Meenu Chhabra's 2020 pay jumps 65% to $3.3M
April 22, 2021
Merrimack Pharmaceuticals CEO Richard Peters' 2019 pay falls 51% to $1.6M
April 22, 2020
Merrimack Pharmaceuticals CEO Richard Peters' 2018 pay slips 13% to $3.3M
September 26, 2019